Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 7Papillomavirus Infections 6Neoplasms 5Breast Neoplasms 4Uterine Cervical Dysplasia 3Melanoma 3Lung Neoplasms 3Herpes Zoster 3Condylomata Acuminata 3Vulvar Neoplasms 2Prostatic Neoplasms 2Influenza, Human 2Anus Neoplasms 2Wilms Tumor 1Whooping Cough 1Waldenstrom Macroglobulinemia 1Vaginal Neoplasms 1Tetanus 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Small Cell Lung Carcinoma 1Sarcoma 1Rheumatic Diseases 1Recurrence 1Psoriasis 1Persistent Infection 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms, Glandular and Epithelial 1Nasopharyngeal Neoplasms 1

Interventions

Brachytherapy 4fludarabine phosphate 3Radiotherapy 3Radiosurgery 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3fludarabine 2aldesleukin 2aflibercept 2Vaccines, Synthetic 2Trastuzumab 2Topotecan 2Therapeutics 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Paclitaxel 2Methods 2Magnetic Resonance Spectroscopy 2Early Intervention, Educational 2Cyclophosphamide 2Counseling 2Cisplatin 23-aminopyridine-2-carboxaldehyde thiosemicarbazone 2tremelimumab 1tipifarnib 1temsirolimus 1entinostat 1durvalumab 1alovudine 1Vinorelbine 1Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Vaginal Neoplasms × Vaccines × Clear all
NCT05680454 2023-01-17

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

Beijing Health Guard Biotechnology, Inc

Phase 1 Completed
160 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡